Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
Hayat Saeed, Medical Laboratory Sciences Graduate, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Clinica Chimica Acta, adding:
“I am excited to share our second publication in Clinica Chimica Acta titled FGL1–hepcidin axis in iron homeostasis and disease!
In this review, we delve into the molecular cross-talk between fibrinogen-like protein 1 (FGL1) and hepcidin, exploring how this novel hepatokine axis regulates iron metabolism and its diagnostic potential in disorders of iron homeostasis.
A special note of gratitude to our supervisor and principal author, Dr. Muhammad Saboor, for his invaluable guidance throughout this research, as well as my dedicated co-authors: Raghad Abdulrahim Fayaz, Shamsa Nabi, Mshael Mohammed and Abeer Mohammed.”
Title: FGL1–hepcidin axis in iron homeostasis and disease
Authors: Muhammad Saboor, Raghad Abdul Rahim, Shamsah Nabi Dad, Hayat Mohsen Mansoor, Mshael Mohammed Nasser, Abeer Mohamed Yusuf
Stay udpated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment
-
Oct 19, 2026, 16:04Hussnain Javaid: New EHA Guidelines for HbSC Disease Management
-
Oct 19, 2026, 15:50Deep Madkaiker: A New Academic Opportunity in Transfusion Medicine at ACTREC
-
Oct 19, 2026, 15:19Why Hematologists Should Care About Diminished Ovarian Reserve in SCD – ASH Education
-
Oct 19, 2026, 14:16Hyperfibrinolysis as an Underrecognized Cause of Bleeding
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions